LMR Partners’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$31.2M Sell
228,600
-24,460
-10% -$3.01M 0.12% 172
2026
Q1
$29.8M Buy
+253,060
New +$35.4M 0.07% 161
2025
Q1
Sell
-22,756
Closed -$3.28M 1594
2024
Q4
$3.28M Sell
22,756
-1,411
-6% -$202K 0.03% 482
2024
Q3
$3.6M Buy
+24,167
New +$3.47M 0.03% 443
2024
Q1
Sell
-8,329
Closed -$1.5M 1283
2023
Q4
$1.5M Buy
8,329
+6,329
+316% +$985K 0.02% 519
2023
Q3
$318K Buy
+2,000
New +$327K ﹤0.01% 598
2022
Q4
Sell
-14,974
Closed -$2.8M 1241
2022
Q3
$2.8M Buy
14,974
+12,258
+451% +$2.58M 0.05% 422
2022
Q2
$441K Sell
2,716
-4,844
-64% -$766K 0.01% 955
2022
Q1
$1.42M Sell
7,560
-3,721
-33% -$707K 0.02% 689
2021
Q4
$2.99M Sell
11,281
-10,772
-49% -$2.9M 0.03% 363
2021
Q3
$6.37M Buy
+22,053
New +$5.66M 0.07% 218
2020
Q4
Sell
-19,729
Closed -$2.91M 604
2020
Q3
$2.91M Sell
19,729
-3,481
-15% -$498K 0.06% 123
2020
Q2
$2.87M Buy
+23,210
New +$2.73M 0.07% 198
2014
Q2
Sell
-24,282
Closed -$313K 539
2014
Q1
$313K Buy
+24,282
New +$348K 0.04% 182

Other funds holding RGEN

LMR Partners's RGEN Position: Q2 2026 in Review

LMR Partners reduced its Repligen (RGEN) stake by 9.7% in Q2 2026, selling an estimated $3.01M and leaving 228,600 shares worth $31.2M. The position accounts for 0.12% of the portfolio, ranked #172.

LMR Partners first reported a position in RGEN in Q1 2014 and has held it in 14 quarters since. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • LMR Partners held 228,600 shares of Repligen worth $31.2M as of Q2 2026.
  • LMR Partners sold 24,460 Repligen shares in Q2 2026, an estimated $3.01M.
  • Repligen made up 0.12% of LMR Partners's portfolio in Q2 2026, its #172 holding.
  • LMR Partners first reported a position in Repligen in Q1 2014 and has held it in 14 quarters since.
  • 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on LMR Partners's 13F filing for Q2 2026, filed 14 Aug 2026.